|
Multiple
Sclerosis (MS)
The Symptoms
Progressively worsening (in some cases) symptoms Blurred Vision, Speech
Problems, Fatigue, Muscle Weakness, Poor Co-ordination, Walking Difficulties.
What causes it?
A Dysfunctional Leaky digestive system leading to a dysfunctional auto immune
system exacerbated by other factors including a diet with too many starchy
foods (breads, pastry, biscuits, breakfast cereals and high starch root
vegetables).
Stress, worry, pharmaceutical drugs (Antibiotics, Steroids,
Ibuprofen, Aspirin etc., Toxic inorganic metals such as Mercury, Viral,
Bacterial Problems.
The Effect
Your body's own immune system attacks the myelin sheath, destroying patchy
areas. This leads to scar tissue forming that in turn blocks or slows the
nerve signals.
The Solution
Clear away the scar tissue, restore a healthy digestive system and to provide
all of the nutrients to repair the damaged tissue.
Testimony
“I
now feel brilliant. Everything has improved. Since last June I have had no
relapses. The tightness in my spine that indicates the presence of MS has
gone, as have the constant pins and needles in my fingers. My balance has
improved and, what is perhaps best of all, the old confident pre-MS me has
returned.” Maureen Rooney
Read more testimonies
How can Serrapeptase Help?
Serrapeptase helps immensely as it clears out all of the inflammation and
dead/scar tissue. By clearing away this problem tissue it enables the nerve
signal to work unimpeded and possibly the bodies own healing system to replace
it with healthy tissue.
There
are no studies that we know of using serrapeptase with MS. You can see
the available type of studies below. We found it useful for MS by chance and
at first were puzzled why it could help. Serrapeptase has been sold as
an anti-inflammatory for about 30 years in Europe and has also been found to
be effective at dissolving non-living tissue and especially internal scarring
and lesions. Our hypothesis is that as the problem with MS is the scar tissue
that forms on the damaged myelin sheath, then the serrapeptase is dissolving
this and allowing the nerves to start to function. If there is no damaging attack
on the myelin sheaf at that point then it may even start to regenerate
(although we do not have any evidence of this). We can only go by the good
remission reports from the users (even with those with non-remissive type) and
an MS Natural Health Clinic that is now using it as its first line. This
clinic is also using our Curcumin98% (extract of turmeric). See the study
below.
back to the
start > >
NEW ORLEANS (Reuters Health) -
Preliminary studies in rats suggest that curcumin, a compound found in the
curry spice turmeric, may block the progression of multiple sclerosis (MS).
According to researcher Dr.
Chandramohan Natarajan of Vanderbilt University in Nashville, Tennessee, rats
with an MS-like illness showed little or no signs of disease symptoms after
being injected with curcumin, while animals without the treatment went on to
severe paralysis.
“We got a very good inhibition of
the disease by treating with curcumin,” Natarajan told Reuters Health. He
presented the findings at the annual Experimental Biology 2002 conference.
No one knows what causes multiple
sclerosis, in which the body’s immune system attacks the protective myelin
sheath surrounding nerve fibres in the brain and spine. Symptoms of multiple
sclerosis include muscle weakness and stiffness, balance and coordination
problems, numbness and vision disturbances.
Interest in the potential
neuroprotective properties of curcumin arose after studies found very low
levels of neurological diseases, such as Alzheimer’s, in elderly Indian
populations. Added to this were studies confirming curcumin as a potent
anti-inflammatory agent, effective in wound healing. And just last fall,
researchers at the University of California, Los Angeles, reported that
curcumin appeared to slow the progression of Alzheimer’s in mice.
In their 30-day study, Natarajan
and co-researcher Dr. John Bright gave injections of 50- and 100-microgram
doses of curcumin, three times per week, to a group of mice bred to develop a
disease called experimental autoimmune encephalomyelitis (EAE)--an autoimmune
condition used by researchers as a model for multiple sclerosis because it
also results in the slow erosion of myelin. They then watched the rats for
signs of MS-like neurological impairment.
By day 15, rats who had not
received curcumin developed EAE to such an extent that they displayed complete
paralysis of both hind limbs, according to Natarajan.
In contrast, rats given the
50-microgram dose of the curry compound showed only minor symptoms, such as a
temporarily stiff tail. And rats given the 100-microgram dose appeared
completely unimpaired throughout the 30 days of the study.
The results didn’t really surprise
Natarajan. “In Asian countries, such as India, China, who are eating more
spicy foods, more yellow compounds like curcumin... there are only very, very
rare reports of MS,” he pointed out. He said the doses the rats received were
roughly equivalent in human terms to those found in a typical Indian diet.
Just how curcumin might work to
thwart the progression of demyelinization remains unclear. But the Nashville
researchers believe it may interrupt the production of IL-12, a protein that
plays a key role in signalling immune cells to launch their assault on the
myelin sheath.
Natarajan stressed that “we have
to do a lot of work on this,” including examining other potential mechanisms
by which curcumin slows EAE and, potentially, MS.
The work remains preliminary, and
MS patients should follow their doctor’s advice when it comes to treating the
disease. Still, Natarajan said adding a little curry to the diet couldn’t
hurt. “I think using this spice in their food could be of help,” he said.
Further Research
Dr. Hector E. Solorzano del Rio,
M.D., Ph.D., D.Sc., chairman of the Program for Studies of Alternative
Medicines of the University of Guadalajara, claims it has been scientifically
proven that enzymes indeed help MS patients.
Dr. Solorzano gives an example
about one of his wheelchair-bound MS patients, named Jose. At 40 years of age,
he had received all known orthodox treatments with no results. After one month
on an enzyme program, Jose felt more strength in all of his muscles. He could
again dress himself; within three months he could walk with some difficulty.
After six months of enzymatic treatment, he was no longer sick. He is very
happy and now lives a productive life.
Important additional factors found
in MS patients are a deficiency of unsaturated fatty acids and other essential
nutrients. Hundreds of patients have been treated with enzymatic therapy, with
good results, not only in Germany or Mexico, but also in many other countries.
It is important to remember that these patients also had a full dietary
program.
back to the
start > >
Click here for Serrapeptase references
How many do I take?
Start with 3 Tablets of Serrapeptase x 3 times per day on an empty stomach and
increase it to 4 x 3 if no relief with 7 days. Then gradually reduce to 1 x 1.
Can I take too many tablets or can it interfere
with any drugs I am taking?
No. It has been used for over 25 years with no side effects reported.
What things can I do to help with MS?
| 1. |
Follow as below (in
order of priority, as much as you can afford) |
| |
|
• |
Take Serrapeptase Enzymes as recommended
|
|
• |
Take Curcumin as recommended, (Stimulates Glutathione) to
protect the myelin sheath during regeneration.
|
|
• |
Treatment with an electro-acupressure device
has proved to be highly effective in treating MS problems. The
HealthPoint unit simply stimulates the body’s own healing system,
and it is effective over a vast range of MS-related problems.
|
|
• |
Sublingual Homocysteine Control Formula
|
|
• |
Using the
Basic Health Plan will ensure appropriate nutrients
and actions are taken to help the healing process
|
|
• |
Exercise by walking fast for 60 minutes, at least 3 times
per week.
|
|
• |
Vitamin D 4000iu daily
|
|
• |
Vitamin E - Build up to 1200iu per day with meals.
|
|
• |
Hemp Oil needed to regenerate myelin sheath.
|
|
• |
Vitamins and Minerals Liquid Formula
|
|
• |
Get more oxygen in your cells by taking Oxygen Promoting
Enzymes or Ozone Therapy or Hyperbaric and eventually exercise by
walking fast for 60 minutes at least 5 times per week.
|
|
Critical to restore the Digestive Tract.
For your Digestive Tract Recovery take (in order of priority): |
|
• |
Essential Herbal Cleanse to cleanse and restore digestive
system and whole body system (optional)
|
|
• |
ProDophilusFOS - Ensures a healthy digestive tract
|
|
• |
L-Glutamine - take 5 gms daily to heal the damaged
digestive tract for 1-2 months.
|
|
• |
Oxygen and Aloe Vera Supplement Take ½oz twice per day to
help heal the digestive tract and support the Probiotic.
|
|
• |
Digestive Enzymes –Ensures proper digestion of food.
|
|
back to the
start > >
Serrapeptase references:
l..
Kee WH. Tan SL, Lee V. Salmon YM. The treatment of breast engorgement with
Serrapeptase (Danzen): a random ized double-blind controlled trial. Singapore
Med J. 1989:30(1):48-54.
2.
M izukoshi, D. et al. A double-blind clinical study of serrapeptase in the
treatment of chronic sinusitis. Igaku Ayrni 109:50-62.1979.
3.
Carratu, L. et al. Physio-chemical and rheological research on mucolytic
activity of serrapeptase in chronic broncho-pneumopathies. Curr. Ther. Res.
28(6):937-951. 1980.
4.
Braga, P.C. et al. Effects of serrapeptase on muco-ciliary clearance in
patients with chronic bronchitis. Curr. Ther. Res. 29(5):738-744,1981.
5.
Mazzonie, A. et al. Evaluation of serrapeptase in acute or chronic
inflammation of otorhinolaryngology pathology: a multicentre, double-blind
randomized trial versus placebo. J. int. Med. Res. 18(5):379-388,1990.
6.
Kakinumu, A. et al. Regression of fibrinolysis in
scalded rats by administration of serrapeptase. Biochem. Pharmacol.
31:2861-2866,1982.
7.
Marly, M. Enzymotherapie anti-inflammatoire a l'aide de la serrapeptase:
resultats cliniques en traumatologie et en ORL. C RTherapeut. 3:9-19,1985.
8.
Odagiri, J. et al. Clinical applications of serrapeptase in sinusitis. Med.
Consult. New Remedy 6:201-209, 1979.
9.
Yamazaki, J. et al. Anti-inflammatory activity of TSP, a protease produced by
a strain of Serratia. Folia Pharmacol. Japon. 6^302-314,1967.
I0.
Harad~, Y. Clinical efficacy of serrapeptase on buccal swelling after radical
operation for chronic sinusitis. Igaku Ayumi 123:768-778.1982.
1
I. Matsudo, A. et at. Effect of serrapeptase (Danzen) on inflammatory edema
following operation for thyropid disease. Med. Consult. New Remedy 18:171-175,
1981.
12.
Fujitani, T. et al. Effect of anti-inflammatory agent on transfer of
antibiotics to the maxillary sinus mucosa in chronic sinusitis.
Otorhinolaryngol. Clin. North Am. 66:557-565. 1976.
13.
Tago. T. and Mitsui, S. Effects of serrapeptase in dissolution of sputum,
especially in patients with bronchial asthma. Jap. Clin. Exp. Med. 49:222-228,
1972.
14.
Mazzonie, A. et al. Evaluation of serrapeptase in acute or chronic
inflammation of otorhinolaryngology pathology: a multicentre, double-blind
randomized trial versus placebo. J. int. Med. Res. 18(5):379-388,1990.
15.
Kase, Y. et al. A new method for evaluating mucolytic expectorant activity and
its application. II. Application to two proteolytic enzymes, serrapeptase and
seaprose. Arzneimittelforschung 32:374-378,1982.
16.
Marriott, C. Modification of the rheoloaical properties of mucus by drugs.
Adv. Exp. Med. Biol. 144^75-84, 1982.
17.
Majima. Y. et al. Effects of orally administered drugs on dynamic
viscoelasticity of human nasal mucus. Am. Rev. Respit. Dis. 141:79-83.1990.
18.
Miyata, K. Intestinal absorption of serrapeptase. J ApplBiochem.
1980:2:111-16.
19.
Aso T. et al. Breast engorgement and its treatment: Clinical effects of Danzen
(serrapeptase) an anti-inflammatory enzyme preparation. The world of
Obstetrics and Gynecology (Japanese). 1981:33:371-9.
20.
Esch PM, Gemgross H. Fabian A. Reduction of postoperative swelling. Objective
measurement of swelling of the upper ankle joint in treatment with
serrapeptase-a prospective study (German). FortschrMed. 1989; 107(4):67-8,
71-2.
21.
Majima Y, lnagaki M, Hirata K. Takeuchi K, M orishita A, Sakakura Y. The
effect of an orally administered proteolytic enzyme on the elasticity and
viscosity of nasal mucus. Arch Otorhinolaryngol. 1988;244(6):355-9.
22.
Selan L, Berlutti F, Passariello C. Comodi-Ballanti MR, Thaller MC.
proteolytic enzymes: a new treatment strategy for prosthetic infections?
Antimicrob Agents Cheroother. 1993; 37(12):2618-21.
23.
Koyama A, Mori J, Tokuda H, Waku M, Anno H, Katayama T, Murakami K, Komatsu H,
Hirata M, Arai T, et al. Augmentation by serrapeptase of tissue permeation by
cefotiam (Japanese). Jpn JAntibiot. 1986; 39(3):761-71.
back to the
start > >
|
